Aeglea BioTherapeutics
year data from first in human study of for the treatment of deficiency | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
May 2020
Slide
1 of 13
Related slides by other companies
Thoughtworks
Results
May 2022
we been a shaping force of digital technology for years data mesh | Thoughtworks
Ashtead Group
Investor Day
April 2021
our wealth of data positions us to innovate the customer experience years | Ashtead Group
KnowBe4
Mergers and Acquisitions
October 2021
the most exploited layer in the human layer according to the data breach investigations report of data breaches involved a human element | KnowBe4
Larimar Therapeutics
Results
November 2022
study objective to evaluate the safety tolerability and profile of a single ascending dose and multiple ascending doses of in patients aged years with ataxia | Larimar Therapeutics
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io